How is the Tissue Microarray Market Poised for Growth: Trends and Opportunities Through 2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What fueled the previous growth in the tissue microarray market?
In recent years, the tissue microarray market has significantly expanded. The market, which currently stands at $12.05 billion in 2024, is predicted to rise to $13.23 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.8%. The historic growth can be linked to the advancements in precision medicine, drug discovery and development, streamlined analysis, increasing occurrence of chronic illnesses, and initiatives in biobanking.
What will be the tissue microarray market size in the future?
Over the coming years, the tissue microarray market is forecasted to experience a swift expansion. It is projected to attain a value of $20.95 billion by 2029, boasting a compound annual growth rate (CAGR) of 12.2%. This projected growth during the estimated period can be ascribed to various factors such as the advent of digital pathology, wider applications, an expanding biopharmaceutical industry, favorable regulatory frameworks, and the incorporation of AI and machine learning. The anticipation for the forecast period encompasses advances in imaging technologies, the creation of 3D tissue microarrays, high-content screening, initiatives towards standardization, and the integration of single-cell analysis.
Get your tissue microarray market report here!
https://www.thebusinessresearchcompany.com/report/tissue-microarray-global-market-report
What main drivers are fueling expansion in the tissue microarray market?
As cancer incidences continue to rise, it’s anticipated this will fuel enlargement of the tissue microarray market. Cancer, a group of diseases manifesting in any body organ or tissue, is characterized by erratic cell growth and invasion towards neighboring body parts or other organs. Tissue microarray is an instrumental tool in oncology for investigating the expression of cancer-associated biomarkers in a variety of tumor samples. For instance, Macmillan Cancer Support, a UK-based cancer charity, published data in June 2022 indicating that the population of individuals living with cancer had hit 3 million in 2022, forecasting a jump to approximately 3.5 million by 2025 and 4 million by 2030 in the UK. Hence, the escalating count of cancer cases is a key driver for the expansion of the tissue microarray market.
What key areas define the segmentation of the global tissue microarray market?
The tissue microarray market covered in this report is segmented –
1) By Type: Immunohistochemistry, Fluorescent In Situ Hybridization, Frozen Tissue Array, Other Types
2) By Technology: Deoxyribonucleic Acid (DNA) Microarray, Polymerase Chain Reaction (PCR), Next-Generation Sequencing, Northern Blotting, Western Blotting
3) By Application: Oncology, Gene Expression Profiling, Single Nucleotide Polymorphism (SNP) Detection, Double-Stranded B-DNA Microarrays, Comparative Genomic Hybridization, Sequencing Bioinformatics
4) By End-User: Pharmaceutical And Biotechnological Companies, Research Organization, Hospitals
Subsegments:
1) By Immunohistochemistry: Automated Immunohistochemistry, Manual Immunohistochemistry, Multiplex Immunohistochemistry
2) By Fluorescent In Situ Hybridization (FISH): Single-Color FISH, Multi-Color FISH, DNA FISH
3) By Frozen Tissue Array: Tissue Microarray from Frozen Samples, Snap-Frozen Tissue Array
4) By Other Types: Nucleic Acid Microarrays, RNA In Situ Hybridization, Paraffin-Embedded Tissue Array
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12236&type=smp
Who are the dominant players expanding their reach in the tissue microarray market?
Major companies operating in the tissue microarray market include Roche Group, Merck & Co. Inc., Thermo Fisher Scientific Inc., Becton, Dickinson Biosciences, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, PerkinElmer Inc., Bio-Techne Corporation, Tristar Group, Evotec SE, Precision For Medicine Inc., Molecular Devices LLC, BioIVT LLC, BioChain Institute Inc., Creative Bioarray Co, 3DHISTECH Ltd., Novus Biologicals LLC, PREMIER Biosoft International Inc., iSpecimen Inc., OriGene Technologies Inc., Bio SB Inc., ProteoGenex Inc., Z Biotech LLC
How are evolving market trends shaping tissue microarray Strategies?
One major trend gaining traction in the tissue microarray market is the formation of strategic partnerships. There is a rising occurrence of key players in this market creating alliances to co-develop technologies related to tissue microarray. An example of this came in November 2022 when The Cureline Group, a US firm specializing in HBS biobanking and laboratory services, collaborated with Cellecta Inc., another US company providing RNAi and CRISPR screening services. This led to the launch of Tissue 2 Target Services where their respective expertise in molecular analysis of cells and tissues and human biospecimen management were fused to provide pre-clinical and translational research facilities focusing on gene target and biomarker discovery services, optimizing workflow productivity. Additionally, in September 2022, a strategic alliance was formed between Ultivue Inc., a US biotech company that designs reagent-based solutions to obtain maximum biological data from cell and tissue samples, and ngTMA, a Translational Research Unit platform from the University of Bern in Switzerland. The primary objective of this partnership is to drive the development of multiplexed immunofluorescence (mIF) assays and to implement novel TMA technology to facilitate spatial analysis in scientific study, improving the quality of TMAs used in clinical and translational research.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12236
Which regions are emerging as leaders in the tissue microarray market?
North America was the largest region in the tissue microarray market in 2024. Asia-Pacific is expected to be the fastest-growing region in the tissue microarray market report during the forecast period. The regions covered in the tissue microarray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Computed Tomography (CT) Scanners Devices And Equipment Global Market Report 2024
Scanner Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/scanner-global-market-report
3D Medical Imaging Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/3d-medical-imaging-devices-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
